In recent months, talk of the United States “overtaking” Venezuela has returned to the political lexicon. The phrase is misleading. There has been no invasion, no annexation, no change of flag. What has shifted is leverage. Under Donald Trump, Washington has once again demonstrated how decisively it can shape Venezuela’s economic and political room for manoeuvre through sanctions, oil access and diplomatic pressure. For healthcare across South America, the consequences are real and immediate.
Venezuela’s health system has been in prolonged decline for more than a decade. Hospitals struggle with shortages of medicines, basic consumables and functioning equipment. Power and water outages remain routine. Clinicians are underpaid, overstretched and often forced to leave. This fragility means that external pressure does not simply squeeze a government. It compresses the capacity of hospitals, clinics and public health programmes to function at all.
When sanctions tighten, supply chains for pharmaceuticals and diagnostics deteriorate further. Even when humanitarian exemptions exist on paper, procurement becomes slower, riskier and more expensive. When sanctions are eased, usually in exchange for oil or political concessions, any marginal improvement tends to stabilise the state rather than rebuild the health system. Care remains hostage to geopolitics.
The effects do not stop at Venezuela’s borders. Millions have left the country, creating one of the largest migration movements in modern Latin American history. Colombia, Brazil, Peru, Ecuador, Chile and Argentina have absorbed the human cost. For their health systems, this has meant sudden increases in demand for primary care, maternity services, mental health support and long term condition management. Border regions in particular have seen public hospitals stretched beyond design capacity. Continuity of care is difficult when patients arrive without records, vaccination histories or stable housing.
There is also a quieter risk. As Venezuela’s disease surveillance capacity weakens, regional public health security erodes. Outbreaks of measles, malaria, dengue and tuberculosis are harder to detect early and harder to contain. Cooperation with bodies such as the Pan American Health Organization becomes politically fraught, and data gaps widen. In public health, silence is rarely neutral. It is dangerous.
Oil remains central to this story. Venezuela’s fiscal capacity to fund healthcare is tied to energy exports. Restrict access and revenues fall, leaving hospitals without resources. Restore access and revenues rise, but spending priorities are shaped by political survival rather than system reform. For neighbouring countries, volatility in oil markets also feeds through into fuel prices, transport costs and the day to day running of health services.
The wider signal to South America is unsettling. Healthcare systems are not insulated from great power politics. Alignment, or perceived misalignment, with Washington can influence access to aid, cooperation and emergency support. This reality pushes governments towards short term calculations when long term health resilience demands regional collaboration.
The lesson is not that Venezuela’s crisis is unique. It is that healthcare has become a pressure point in geopolitical competition. When leverage is applied to states with fragile systems, patients feel it first. South America is already paying that price.
